Provectus Biopharmaceuticals, Inc.
PVCT
Revenue
254.99k
▲16.92k▲7.11%
3 Months ChangeAssets
856.43k
▼-222.56k▼-20.63%
3 Months ChangeLiabilities
8.37M
▼-159.14k▼-1.87%
3 Months ChangeFree Cash Flow
-2.81M
▼-2.81M-∞%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-19
Form 8-K
ID: 0001493152-24-033053
2024-08-13
Form 10-Q
ID: 0001493152-24-031524
2024-07-17
Form 8-K
ID: 0001493152-24-028157
2024-06-25
Form 8-K
ID: 0001493152-24-025080
2024-06-21
Form 8-K
ID: 0001493152-24-024661
2024-06-20
Form 8-K
ID: 0001493152-24-024449
2024-05-14
Form 10-Q
ID: 0001493152-24-019184
2024-04-16
Form 8-K
ID: 0001493152-24-014848
2024-03-27
Form 8-K
ID: 0001493152-24-011443
2024-03-26
Form 8-K
ID: 0001493152-24-011327